SUN Pharmaceutical Industries Limited — Famotidine Exporter Profile
Indian Pharmaceutical Exporter · #13 for Famotidine · $1.1M export value · DGFT Verified
SUN Pharmaceutical Industries Limited is the #13 Indian exporter of Famotidine with $1.1M in export value and 48 verified shipments. SUN Pharmaceutical Industries Limited holds a 2.0% market share in Famotidine exports across 2 countries. The company exports 118 pharmaceutical products worth $979.8M across 25 therapeutic categories.
SUN Pharmaceutical Industries Limited — Famotidine Export Profile: Buyers & Destinations
Where Does SUN Pharmaceutical Industries Limited Export Famotidine?
SUN Pharmaceutical Industries Limited exports Famotidine to 2 countries. The largest destination is SRI LANKA accounting for 71.3% of SUN Pharmaceutical Industries Limited's Famotidine shipments. These destinations reflect SUN Pharmaceutical Industries Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Famotidine from SUN Pharmaceutical Industries Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| TO THE ORDER | SRI LANKA | $179.3K | 6 |
| M/S. JDS CO., LTD. | MYANMAR | $138.3K | 6 |
| TO THE ORDER OF | SRI LANKA | $86.1K | 5 |
| NOTIFY EMERCHEME NB CEYLON LIMITED | SRI LANKA | $63.7K | 2 |
| TO THE ORDER OF HATTON NATIONAL BAN | SRI LANKA | $55.9K | 2 |
| TO THE ORDER SAMPATH BANK PLC, | SRI LANKA | $33.9K | 1 |
| JDS CO., LTD, | MYANMAR | $30.0K | 3 |
| NOTIFY EMERCHEME NB CEYLON LTD | SRI LANKA | $29.0K | 1 |
| MS JDS CO LTD | MYANMAR | $26.1K | 1 |
| TO THE HONGKONG AND SHANGHAI BANKIN | SRI LANKA | $18.8K | 1 |
SUN Pharmaceutical Industries Limited supplies Famotidine to 20 buyers globally. The largest buyer is TO THE ORDER (SRI LANKA), followed by M/S. JDS CO., LTD. (MYANMAR) and TO THE ORDER OF (SRI LANKA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Famotidine Export Value and How Much Does SUN Pharmaceutical Industries Limited Contribute?
India exported $40.4M worth of Famotidine through 2,750 shipments from 152 suppliers to 66 countries, serving 302 buyers globally. SUN Pharmaceutical Industries Limited contributes $1.1M to this total, accounting for 2.0% of India's Famotidine exports. SUN Pharmaceutical Industries Limited ships Famotidine to 2 countries through 20 buyers.
What Is the Average Shipment Value for SUN Pharmaceutical Industries Limited's Famotidine Exports?
SUN Pharmaceutical Industries Limited's average Famotidine shipment value is $22.9K per consignment, based on 48 shipments totaling $1.1M. The largest destination is SRI LANKA (71.3% of SUN Pharmaceutical Industries Limited's Famotidine exports).
How Does SUN Pharmaceutical Industries Limited Compare to Other Indian Famotidine Exporters?
SUN Pharmaceutical Industries Limited ranks #13 among 152 Indian Famotidine exporters with a 2.0% market share. The top 3 exporters are VKT PHARMA PRIVATE LIMITED ($8.7M), ANNORA PHARMA PRIVATE LIMITED ($8.1M), MYLAN LABORATORIES LIMITED ($7.5M). SUN Pharmaceutical Industries Limited processed 48 shipments to 2 destination countries.
What Famotidine Formulations Does SUN Pharmaceutical Industries Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| FAMOCID 20 MG TABLETS (FAMOTIDINE TABLET | $146.2K | 5 |
| FAMOCID-20 MG TABLETS (Famotidine Tablet | $90.6K | 2 |
| FAMOCID 40 MG TABLETS (Famotidine Tablet | $77.7K | 5 |
| FAMOCID 20 MG TABLETS FAMOTIDINE TABLETS USP 20MG PACK : 10*10 Batch : JME0853A | $50.0K | 1 |
| FAMOCID 20 MG TABLETS (FAMOTIDINE TABLETS, USP, 20MG) PACK : 10*10 BATCH : JME1102APCS | $50.0K | 1 |
| FAMOCID 20 MG TABLETS (FAMOTIDINE TABLETS, USP, 20MG) PACK : 10*10 BATCH : JMF0297A | $50.0K | 1 |
| FAMOCID-20 MG TABLETS (Famotidine Tablets USP 20mg)PACK : 10*10 Batch : JMF1195A, JMF1196A | $50.0K | 1 |
| FAMOCID 20 TABLETS (Famotidine) PACK : 10*10 Batch : JMF1420A, JMF1419A | $49.1K | 1 |
| FAMOCID 40 TABLETS (Famotidine Tablets, | $33.8K | 1 |
| FAMOCID 40 MG TABLETS (Famotidine Tablets, USP, 40mg)PACK : 10*10 Batch : JMF1198A | $32.7K | 2 |
SUN Pharmaceutical Industries Limited exports 38 distinct Famotidine formulations including tablets, capsules, syrups, and combination drugs. The top formulation is FAMOCID 20 MG TABLETS (FAMOTIDINE TABLET with 5 shipments worth $146.2K.
How Does SUN Pharmaceutical Industries Limited Compare to Nearest Famotidine Exporters?
Exporters ranked immediately above and below #13 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 11 | MARKSANS PHARMA LIMITED | $1.2M | 106 | 2 | $11.4K |
| 6 | MEDREICH LIMITED | $1.1M | 23 | 1 | $50.0K |
| 13 | SUN PHARMACEUTICAL INDUSTRIES LIMITED ★ | $1.1M | 48 | 2 | $22.9K |
| 12 | APL HEALTHCARE LIMITED | $1.0M | 20 | 1 | $50.0K |
| 10 | AUROBINDO PHARMA LIMITED | $400.0K | 8 | 1 | $50.0K |
SUN Pharmaceutical Industries Limited ranks #13 among 152 Indian Famotidine exporters. Average shipment value of $22.9K compared to the market average of $265.7K. The closest competitors by value are MARKSANS PHARMA LIMITED and MEDREICH LIMITED.
Which Indian Ports Ship Famotidine Exports?
| Port | Shipments | % Share |
|---|---|---|
| DELHI AIR CARGO ACC (INDEL4) | 264 | 9.6% |
| HYDERABAD ICD | 251 | 9.1% |
| SAHAR AIR | 239 | 8.7% |
| DELHI AIR | 188 | 6.8% |
| NHAVA SHEVA SEA (INNSA1) | 163 | 5.9% |
| SAHAR AIR CARGO ACC (INBOM4) | 155 | 5.6% |
| HYDERABAD ICD (INSNF6) | 153 | 5.6% |
| HYDERABAD AIR | 86 | 3.1% |
Geopolitical & Trade Policy Impact on SUN Pharmaceutical Industries Limited's Famotidine Exports
Sun Pharma's export operations, valued at $979.8 million, are significantly influenced by current geopolitical events. The ongoing Israel-Iran tensions have led to disruptions in the Red Sea shipping routes, a critical corridor for Indian pharmaceutical exports to Europe and North Africa. Major shipping lines have imposed 'Emergency Risk Surcharges,' increasing freight costs and extending transit times by 10–15 days. These delays pose risks to the integrity of time-sensitive and temperature-controlled pharmaceutical shipments. (pharmaceuticalcommerce.com)
In the United States, policy shifts towards domestic manufacturing and the imposition of tariffs on imported pharmaceuticals have created challenges for Indian exporters. Sun Pharma, which supplies a substantial portion of generics to the U.S. market, faces potential reductions in export volumes due to these protectionist measures. The company is exploring strategies such as establishing local partnerships and investing in U.S.-based manufacturing to mitigate these impacts. (odrindia.in)
The European Union's implementation of the Carbon Border Adjustment Mechanism (CBAM) introduces additional compliance requirements for exporters. Sun Pharma must adapt to these regulations to maintain its market presence in the EU, necessitating investments in sustainable manufacturing practices and comprehensive reporting mechanisms. (sgeexport.com)
SUN Pharmaceutical Industries Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards remains a critical focus for Sun Pharma. The company has encountered challenges with the U.S. FDA, including import alerts and non-compliance letters for certain facilities. Addressing these issues involves implementing corrective actions and awaiting reinspection to resume full operations. (business-standard.com)
Globally, the pharmaceutical industry faces increasing scrutiny regarding quality standards. Sun Pharma's commitment to adhering to Good Manufacturing Practices (GMP) and other regulatory requirements is essential to maintain its export licenses and market reputation. Continuous investment in quality control systems and compliance infrastructure is imperative to navigate the evolving regulatory landscape.
About SUN Pharmaceutical Industries Limited
SUN Pharmaceutical Industries Limited exports 118 products worth $979.8M. Beyond Famotidine, top products include Strip, Esomeprazole, Magnesium, Calcium, Omeprazole. View the complete SUN Pharmaceutical Industries Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Famotidine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Famotidine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: SUN Pharmaceutical Industries Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 50 individual customs records matching SUN Pharmaceutical Industries Limited exporting Famotidine, covering 38 formulations to 2 countries via 20 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 66+ countries, 302+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Famotidine Export Data from SUN Pharmaceutical Industries Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for SUN Pharmaceutical Industries Limited's Famotidine exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
SUN Pharmaceutical Industries Limited
Full Company Profile →
118 products · $979.8M total trade · 25 categories
Famotidine Stats
Company Overview
Top Products by SUN Pharmaceutical Industries Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for SUN Pharmaceutical Industries Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Famotidine. For current shipment-level data, contact TransData Nexus.